It didn’t take long for Kennesaw State University student Lilianna Kocai to discover a passion for research. All it took was a little nudge from assistant professor Carl Saint-Louis. As a freshman in ...

Recursion is advancing REC-617, a promising reversible, non-covalent CDK7 inhibitor, showing potential in treating advanced solid tumors with positive interim phase 1 data. Read more here.

ConferenceFirst-In-Human Data about the Treatment of Muscle-Invasive Bladder Cancer with Pentixapharm’s Lu177-PentixaTher to be Presented at ASCO-GU 2025 13.02.2025 / 14:10 CET/CESTThe issuer is ...

Netflix benefits from shift to DTC media, sports pivot, and content rationalization, driving revenue and free cash growth.

A brand-new addition this year is the Pittcon Pups – meet adorable local dogs of all ages looking for their fur-ever home. Whether you’re just there for some puppy snuggles or hoping to meet your new ...

(AML) patients across both original and expansion cohorts remain in complete remission (CR), with a median follow-up of 20.1 months AML patients treated demonstrated one-year ...

According to Instarem’s global head, Yogesh Sangle, “While corporate income tax rebates are a welcome measure for profitable ...